Position in PMVP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$614,942
+$57,268 QoQ
Shares Held
495,922
+11.2% QoQ
Ownership
0.930%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. PMVP ranks #345 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in PMVP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $614,942 | 495,922 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $557,674 | 446,140 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $604,548 | 431,820 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $458,665 | 432,704 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $469,562 | 430,792 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $636,781 | 421,710 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $644,814 | 432,762 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $692,912 | 427,724 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,535,332 | 903,137 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,667,041 | 860,336 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,958,436 | 807,563 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,665,790 | 745,334 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,177,349 | 666,111 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,656,522 | 650,175 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,677,177 | 645,141 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,058,845 | 565,533 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $9,421,112 | 452,503 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,587,376 | 458,328 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,917,495 | 433,473 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $11,893,862 | 348,181 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $8,093,768 | 246,086 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $15,121,864 | 245,844 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,171,500 | 33,000 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||